WntRx Pharmaceuticals develops non-toxic selective drugs for the treatment of patients with unmet medical needs.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Boston
State: Massachusetts
Zip:
Country: United States
WntRx Pharmaceuticals develops non-toxic selective drugs for the treatment of patients with colorectal cancer and critical unmet medical needs. It specializes in the development of oncogenic-specific inhibitors of Wnt signaling, a pathway aberrantly activated in a multitude of cancers. The company was founded in 2013 and is headquartered in Boston, Massachusetts.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|